Also listed on Serologicals Royalty Company, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 17, 2027 · High confidence
20-year base term ended May 17, 2026
Held by EMD Millipore Corporation
Filed May 17, 2006 as application 11/435,930 · Granted Dec 15, 2009
Base term plus 335 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
May 17, 2006
May 17, 2006
Term ends
Apr 17, 2027
Apr 17, 2027
Granted
Dec 15, 2009
Dec 15, 2009
base term
patent term adjustment
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
335
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 335 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 17, 2006, when this application, 11/435,930, was filed | May 17, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +335 days, USPTO patent term adjustment record | Apr 17, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 17, 2027 | High confidence |
This family
| US 7,632,661 | this patent Apr 2027 | Apr 2027 |
| Application 12/584,634 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 30, 2006 Reel 17880, frame 838 | Simpson, David J.; Williams, Steven G.; Irvine, Alistair S. | Serologicals Investment Company Inc. | Assignment of Assignor's Interest |
| Mar 9, 2007 Reel 18992, frame 632 | Serologicals Royalty Company | Serologicals Finance Company | Merger |
| Mar 9, 2007 Reel 18993, frame 805 | Serologicals Investment Company | Serologicals Royalty Company | Merger |
| Mar 9, 2007 Reel 18993, frame 815 | Serologicals Finance Company | Serologicals Corporation | Merger |
| Mar 9, 2007 Reel 18997, frame 716 | Serologicals Corporation | Millipore Corporation | Merger |
| Apr 27, 2007 Reel 19220, frame 355 | Serologicals Investment Company | Serologicals Royalty Company | Merger |
| Apr 27, 2007 Reel 19220, frame 389 | Serologicals Royalty Company; Serologicals Finance Company; Serologicals Corporation | Serologicals Finance Company; Serologicals Corporation; Millipore Corporation | Merger |
| Apr 27, 2007 reel/frame not recorded | Serologicals Royalty Company; Serologicals Finance Company; Serologicals Corporation | Serologicals Finance Company | Merger |
| Apr 27, 2007 reel/frame not recorded | Serologicals Royalty Company; Serologicals Finance Company; Serologicals Corporation | Serologicals Corporation | Merger |
| Apr 27, 2007 reel/frame not recorded | Serologicals Royalty Company; Serologicals Finance Company; Serologicals Corporation | Millipore Corporation | Merger |
| Apr 8, 2008 Reel 20762, frame 580 | Serologicals Investment Company | Serologicals Royalty Company | Corrective Assignment to Correct the All of It - Client Wishes to Record Each Merger Separately. Previously Recorded on Reel 019220 Frame 0355. Assignor(S) Hereby Confirms the Merger from Serologicals Investment Company to Final Owner Millipore Corporation.. |
| Apr 8, 2008 Reel 20762, frame 587 | Serologicals Finance Company | Serologicals Corporation | Merger |
| Apr 8, 2008 Reel 20762, frame 592 | Serologicals Royalty Company | Serologicals Finance Company | Corrective Assignment to Correct the All Patents Listed Previously Recorded on Reel 019220 Frame 0389. Assignor(S) Hereby Confirms the Serologicals Royalty Company Merger Through to Millipore Corporation. |
| Apr 8, 2008 Reel 20762, frame 599 | Serologicals Corporation | Millipore Corporation | Corrective Assignment to Correct the All Patents Listed Previously Recorded on Reel 019220 Frame 0389. Assignor(S) Hereby Confirms the Merger from Serologicals Royalty Company Through to Millipore Corporation. |
| Jan 31, 2012 Reel 27620, frame 891 | Millipore Corporation | EMD Millipore Corporation | Change of Name |
| Feb 15, 2018 Reel 45341, frame 166 | EMD Millipore Corporation | EMD Millipore Corporation | Change of Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2027
Term ends Apr 17, 2027. No further fees fall due before then
Note
The 335 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
5
later US patents cite this one
That is below the median of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.